Synapse Open Synapse
Tech

The FDA wants to pull its approval of a drug. It’s not so easy.

Ars Technica · · 12 min read

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

Latest from Ars Technica